Most women unaware of their Alzheimer’s risk, Cleveland Clinic survey finds
By
Alicia Lasek (f3)
Jun 30, 2022
Fully 82% of U.S. women are unaware of their relatively high odds of developing Alzheimer’s disease. And most have not addressed key risk factors with a healthcare provider.
Specialty care is out of reach for most dementia patients: study
By
Alicia Lasek
Sep 04, 2019
Most dementia patients do not receive diagnosis or care from specialists, a new study has found. An “unspecified dementia” diagnosis is common.
Want to ward off dementia? Follow Madonna’s lead
By
May 17, 2016
If you really want to help cut your risks of cognitive impairment and memory loss, it might be time to go outside your comfort zone and take a few tips from the Material Girl herself.
You’re not paranoid if the world is out to get you
By
John O'Connor
Jun 11, 2012
Are long-term care operators overly paranoid? That answer probably depends on your definition of “overly.”
Mid-life racial discrimination in Black Americans tied to Alzheimer’s later on, study finds
By
Kristen Fischer
Apr 12, 2024
Racial discrimination during midlife is linked to Alzheimer’s disease, a new study finds.
FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.
Oh, baby! Dolls bring new life to nursing home
By
Kimberly Marselas
Feb 28, 2018
Volunteer Sandy Cambron did her best to rekindle parental love among dozens of memory-impaired residents at Kentucky’s Park Terrace Health Campus — one lifelike baby doll at a time.
Report: Monoclonal antibodies for dementia lack clear benefits, show risks
By
Kristen Fischer
Jan 23, 2024
Even though amyloid-reducing monoclonal antibodies (MABs) are on the market and some research shows they may treat Alzheimer’s disease and dementia, a new research review found there aren’t clear benefits...